Cargando…

C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease

PURPOSE: To differentiate adenoviral pharyngoconjunctival fever (PCF) from acute Kawasaki disease (KD) using laboratory tests before results of virus-real time polymerase chain reaction and ophthalmologic examination are obtained. METHODS: Baseline patient characteristics and laboratory measurements...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jung Eun, Kang, Hee Won, Hong, Young Mi, Sohn, Sejung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Pediatric Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807985/ https://www.ncbi.nlm.nih.gov/pubmed/29441107 http://dx.doi.org/10.3345/kjp.2018.61.1.12

Ejemplares similares

Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide
por: Choi, Jung Eun, et al.
Publicado: (2018)

Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age
por: Bae, Hyun Kyung, et al.
Publicado: (2014)

Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease
por: Jun, Heul, et al.
Publicado: (2016)

Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease
por: Lee, Sang Hoon, et al.
Publicado: (2017)

N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease
por: Zheng, Xiaolan, et al.
Publicado: (2020)

A swimming pool-associated outbreak of pharyngoconjunctival fever caused by human adenovirus type 4 in Beijing, China
por: Li, Jie, et al.
Publicado: (2018)

Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir
por: Hanaoka, Nozomu, et al.
Publicado: (2022)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
por: Dahdah, Nagib, et al.
Publicado: (2013)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection
por: Kim, Jong Han, et al.
Publicado: (2018)

Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease?
por: Lee, Goni, et al.
Publicado: (2013)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
por: Ducros, Jacques, et al.
Publicado: (2020)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population
por: Lee, Kyung-Hoon, et al.
Publicado: (2010)

Prognostic value of amino terminal pro-b-type natriuretic peptide in septic patients
por: Maroto, Fernando, et al.
Publicado: (2008)

Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
por: Zachariah, Justin P, et al.
Publicado: (2016)

The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study
por: Shao, Shuran, et al.
Publicado: (2019)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review
por: Cavalcante, Pâmela Nogueira, et al.
Publicado: (2023)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

N-terminal pro–B-type natriuretic peptide levels in normotensive and hypertensive dogs with myxomatous mitral valve disease stage B
por: Jang, In Sung, et al.
Publicado: (2023)

N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions
por: Kim, Shin-Jae, et al.
Publicado: (2008)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

The predictive value of brain natriuretic peptide or N-terminal pro-brain natriuretic peptide for weaning outcome in mechanical ventilation patients: Evidence from SROC
por: Liu, Jian, et al.
Publicado: (2021)

Correlation Between Levels of N-terminal Pro-B-Type Natriuretic Peptide and Degrees of Heart Failure
por: Song, Bong Geun, et al.
Publicado: (2005)

Predictive value of N-terminal pro-brain natriuretic peptide among critically ill patients
por: Cubrilo-Turek, M, et al.
Publicado: (2012)

Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome
por: Bao, Yuanyuan, et al.
Publicado: (2011)

Comparison of N-Terminal Pro B-Natriuretic Peptide and Echocardiographic Indices in Patients with Mitral Regurgitation
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2010)

Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery
por: Liu, Hua, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_be8lgotftpvag1kc7nft07p6e6